UNSPSC 51411802: Cetiedil

This classification denotes a vasodilating agent with the molecular formula C20H31NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 621RT200TO, chemically known as 3-thiopheneacetic acid, alpha-cyclohexyl-, 2-(hexahydro-1h-azepin-1-yl)ethyl ester but generally known as cetiedil, which bears US NIH Compound Identifier 66384. European Medicines Agency schedules Cetiedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07450MIG.

UNSPSC 51411802 Cetiedil is a Commodity code under which state and local governments procure advanced life support medications and pharmaceutical products for emergency medical services, hospital systems, and state health benefit programs. Recent solicitations show buying concentrated in specific injectable medications—epinephrine, adenosine, labetalol, and diltiazem formulations—supplied to fire rescue operations and distributed through authorized pharmaceutical wholesalers to state agency facilities. The issuing bodies include city purchasing departments (Tampa Fire Rescue), state health agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), reflecting procurement patterns across municipal emergency services, state Medicaid and employee health programs, and regional cooperative arrangements. The work entails furnishing FDA-compliant pharmaceuticals with certified supply chain security, maintaining minimum shelf life and expiration guarantees, arranging timely delivery and expired-product replacement, and submitting comprehensive product and pricing documentation including National Drug Codes, Safety Data Sheets, and accessibility conformance reports where required.

Activity in this code spans Florida, Texas, and Minnesota with participation of multistate cooperatives reaching Oregon and other allied jurisdictions. Representative recent solicitations include the City of Tampa's invitation for bids (IFB 26P00188, due April 8, 2026) for four advanced life support medication line items totaling an estimated $40,000 contract value for Tampa Fire Rescue with a one-year term and renewal options, and the Minnesota Department of Administration's RFP (S1070000015802, due March 26, 2026) to establish multi-award contracts for generic and OTC pharmaceuticals across participating state and local facilities through three authorized wholesalers, with pricing weighted at 75 percent and contract effectiveness set for July 1, 2026. The Texas HHS Commission issued an exploratory RFI (HHS0017013, response due April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager channels, signaling emerging procurement strategy in state pharmacy benefit design. The Tampa solicitation carries a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount, and MMCAP requires vendors to maintain multiple insurance coverage thresholds, comply with cGMP and Drug Supply Chain Security Act certification, and accept performance penalty structures.